<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03839979</url>
  </required_header>
  <id_info>
    <org_study_id>One million healthy citizen 18</org_study_id>
    <nct_id>NCT03839979</nct_id>
  </id_info>
  <brief_title>HCV Viral Hepatitis, Blood Sugar Level and Systolic Blood Pressure in Egypt</brief_title>
  <official_title>Association Between HCV Viral Hepatitis, Blood Sugar Level and Systolic Blood Pressure in the Egyptian Population</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cairo University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cairo University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      An observational double-blind cohort study that examined the association between HCV viral
      hepatitis, blood sugar level and systolic blood pressure in the Egyptian population
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      a cohort study on greater than 70000 Egyptian patients had been conducted. for all
      patients,1- we detected the Hepatitis C Virus (HCV) RNA antigens ( hepatitis C virus)presence
      using BIOLINE HCV kits( qualitative test for diagnosis of hepatitis C virus in the blood) 2-
      Investigators measured blood sugar levels for each patient using ACCU-CHEK kits(finger stick
      sugar level measurement) 3- Measured systolic blood pressure for each patient was measured
      using mercury meters.

      4-for all patients investigators obtained full medical history regarding the presence or
      absence of chronic diabetes, chronic hypertension, coronary artery disease, kidney impairment
      with dialysis or chronic obstructive pulmonary disease.

      5- for all patients investigators listed age, gender, and body mass index. 66122 patients
      were negative for HCV and 5853 were positive for HCV. Investigators measured the association
      between HCV presence, high blood sugar levels and high systolic blood pressure.

      It is supposed that this is the largest study in the world that examined both associations.

      In a word, this study was responding to a specific question: is hepatitis c virus presence is
      associated with high blood pressure or high sugar level or both or not associated???
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">October 1, 2018</start_date>
  <completion_date type="Actual">January 31, 2019</completion_date>
  <primary_completion_date type="Actual">December 31, 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>HCV diagnosis</measure>
    <time_frame>20 minutes</time_frame>
    <description>Detection of patients who are HCV positive or negative</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Measurement of blood sugar level in mg/dl</measure>
    <time_frame>1 minute</time_frame>
    <description>Detection of the percentage of patients with high blood sugar level in HCV positive or negative patients</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Measurement of systolic blood pressure in mmHg</measure>
    <time_frame>1 minute</time_frame>
    <description>Detection of the percentage of patients with high systolic blood pressure in HCV positive or negative patients</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">71975</enrollment>
  <condition>Hepatitis C, Acute</condition>
  <condition>Diabetes</condition>
  <condition>Hypertension</condition>
  <arm_group>
    <arm_group_label>HCV positive patients</arm_group_label>
    <description>Patients tested positive for the hepatitis c virus antibodies by BIOLINE HCV kits.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>HCV negative patients</arm_group_label>
    <description>Patients tested negative for the hepatitis c virus antibodies by BIOLINE HCV kits.</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>BIOLINE HCV kits</intervention_name>
    <description>We used BIOLINE HCV kits to detect the presence of HCV antibodies in stick blood samples of all recruited patients.</description>
    <arm_group_label>HCV negative patients</arm_group_label>
    <arm_group_label>HCV positive patients</arm_group_label>
    <other_name>diagnosis of viral hepatitis C</other_name>
  </intervention>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>ACCU-CHEK kits</intervention_name>
    <description>For all patients, we measured random blood sugar levels by stick blood samples using ACCU-CHEK kits.</description>
    <arm_group_label>HCV negative patients</arm_group_label>
    <arm_group_label>HCV positive patients</arm_group_label>
    <other_name>measurement of blood sugar level</other_name>
  </intervention>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>ErKameter 3000 mercury manometer</intervention_name>
    <description>For all patients, we measured systolic blood pressure using ErKameter 3000 mercury manometer.</description>
    <arm_group_label>HCV negative patients</arm_group_label>
    <arm_group_label>HCV positive patients</arm_group_label>
    <other_name>blood pressure measurement</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Egyptian patients aged 18-80 years.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria

          -  Egyptian citizens from 18 years to 80 years.

        Exclusion Criteria:

          -  Patients younger than 18 years or older than 80 years
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Egyptian Ministry of Health</name>
      <address>
        <city>Asyut</city>
        <zip>01234567</zip>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>February 2019</verification_date>
  <study_first_submitted>February 9, 2019</study_first_submitted>
  <study_first_submitted_qc>February 12, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">February 15, 2019</study_first_posted>
  <last_update_submitted>February 12, 2019</last_update_submitted>
  <last_update_submitted_qc>February 12, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">February 15, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Cairo University</investigator_affiliation>
    <investigator_full_name>Mina Wageh Mohareb</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hepatitis A</mesh_term>
    <mesh_term>Hepatitis C</mesh_term>
    <mesh_term>Hepatitis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>No individual data will be shared with other researchers.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

